Northwestern University Feinberg School of Medicine

Skin Disease Research Center

News and Announcements

Read the latest news from the Skin Disease Research Center at Northwestern University Feinberg School of Medicine. The links below take you to articles where you can learn more about the center, our leadership and our member’s latest achievements.

Announcements

  • Skin Tissue Engineering Core Director, Dr. Bethany Perez White, Receives K01 Award
    08.30.2018

    Congratulations to the Skin Tissue Engineering Core Director, Dr. Bethany Perez White, for receiving a K01 award for her work in understanding the role of EphA2 in building epidermal tight junctions in atopic dermatitis! Please click here for further information. 

     

  • Skin Disease Research Center Director, Amy Paller, MD, selected as the recipient of the 2018 Wilma Bergfeld MD Visionary and Leadership Award
    12.11.2017

    The Skin Disease Research Center is proud to announce that our very own director, Amy Paller, MD, has been selected by her colleagues of the Women's Dermatologic Society to be the recipient of the 2018 Wilma Bergfeld, MD Visionary & Leadership Award. 

    She will receive the award in San Diego on Sunday, February 18, 2018. 

     

  • Roopal Kundu, MD, featured in Northwestern Magazine's Fall Issue
    11.01.2017

    Click here to view the story on Assistant Professor of Dermatology and Associate Dean for Admissions, Roopal Kundu, MD.

     

    

     

     

  • Dermatology featured in Northwestern Magazine's Fall Issue
    11.01.2017

    Click here to view the feature on the Department of Dermatology.

     

     

  • Eversight announces grant award for Northwestern University researcher, Han Peng, PhD
    08.18.2017

    hp1

    ANN ARBOR, Mich. — Eversight, a global nonprofit network of eye banks, has awarded a $15,000 Eye and Vision Research Grant to Northwestern University’s Han Peng, Ph.D.

    Dr. Peng was among nine recipients who received grants from Eversight for projects that aligned with the organization’s mission to restore sight and prevent blindness. The awards were determined by an independent review panel composed of distinguished scientists, ophthalmologists and health services researchers.

    Dr. Peng, a research assistant professor in the department of dermatology at Feinberg School of Medicine, is investigating a possible approach for improving the treatment of limbal stem cell deficiency (LSCD), a problem that is often not recognized and treated in its early stages and may lead to corneal ulceration, scarring, chronic pain and vision loss.

    LSCD occurs because of the loss of limbal epithelial stem cells, but Dr. Peng’s research hypothesizes that an enzyme his team has identified, factor inhibiting hypoxia-inducible factor 1 (FIH-1), may preserve more stem cells. The establishment of stem-cell enriched cultures has the potential to significantly improve the outcome of corneal transplantation for patients with LSCD.

    The Eye and Vision Research Grant program has awarded more than $3.5 million since 1980 to stimulate new and pioneering research. Several of these grant projects have led to larger studies and financial support from the National Institutes of Health.

    “There’s a real void when it comes to funding the initial investigative work that can launch new and groundbreaking discoveries,” said Dr. Gregory Grossman, Eversight Director of Research. “But Eversight is committed to supporting research that may potentially lead to innovative therapies and treatments.”

    The Eversight Center for Eye and Vision Research is one of the only eye bank-led programs focused on providing scientists with innovative resources they need to find new cures and treatments for blinding eye conditions. For more information, visit eversightvision.org/research.

    hp2

    hp3

     

    – More –

    About Eversight: Eversight is a charitable, 501(c)(3) not-for-profit organization whose mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Our network of community eye banks—in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea—is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. For more information, visit eversightvision.org.

  • Outstanding Core Facility Award
    07.10.2015

    Skin Disease Research Center has received the Office of Research’s Outstanding Core Facility Award for 2015. This Award is bestowed on facilities that are scored in the top 10% of all Northwestern Core Facilities. The leadership of the SDRC are both humbled and proud to once again receive this award as it is a testament to our mission to provide the best services to our clients. As always, we are committed to continuously improve each of the SDRC cores and thank our clients for their continued use and support of these core facilities.

News

  • Skin Disease Research Center Director, Amy Paller, MD, selected as the recipient of the 2018 Wilma Bergfeld MD Visionary and Leadership Award
    12.11.2017

    The Skin Disease Research Center is proud to announce that our very own director, Amy Paller, MD, has been selected by her colleagues of the Women's Dermatologic Society to be the recipient of the 2018 Wilma Bergfeld, MD Visionary & Leadership Award. 

    She will receive the award in San Diego on Sunday, February 18, 2018. 

     

  • Roopal Kundu, MD, featured in Northwestern Magazine's Fall Issue
    11.01.2017

    Click here to view the story on Assistant Professor of Dermatology and Associate Dean for Admissions, Roopal Kundu, MD.

     

    

     

     

  • Dermatology featured in Northwestern Magazine's Fall Issue
    11.01.2017

    Click here to view the feature on the Department of Dermatology.

     

     

  • Eversight announces grant award for Northwestern University researcher, Han Peng, PhD
    08.18.2017

    hp1

    ANN ARBOR, Mich. — Eversight, a global nonprofit network of eye banks, has awarded a $15,000 Eye and Vision Research Grant to Northwestern University’s Han Peng, Ph.D.

    Dr. Peng was among nine recipients who received grants from Eversight for projects that aligned with the organization’s mission to restore sight and prevent blindness. The awards were determined by an independent review panel composed of distinguished scientists, ophthalmologists and health services researchers.

    Dr. Peng, a research assistant professor in the department of dermatology at Feinberg School of Medicine, is investigating a possible approach for improving the treatment of limbal stem cell deficiency (LSCD), a problem that is often not recognized and treated in its early stages and may lead to corneal ulceration, scarring, chronic pain and vision loss.

    LSCD occurs because of the loss of limbal epithelial stem cells, but Dr. Peng’s research hypothesizes that an enzyme his team has identified, factor inhibiting hypoxia-inducible factor 1 (FIH-1), may preserve more stem cells. The establishment of stem-cell enriched cultures has the potential to significantly improve the outcome of corneal transplantation for patients with LSCD.

    The Eye and Vision Research Grant program has awarded more than $3.5 million since 1980 to stimulate new and pioneering research. Several of these grant projects have led to larger studies and financial support from the National Institutes of Health.

    “There’s a real void when it comes to funding the initial investigative work that can launch new and groundbreaking discoveries,” said Dr. Gregory Grossman, Eversight Director of Research. “But Eversight is committed to supporting research that may potentially lead to innovative therapies and treatments.”

    The Eversight Center for Eye and Vision Research is one of the only eye bank-led programs focused on providing scientists with innovative resources they need to find new cures and treatments for blinding eye conditions. For more information, visit eversightvision.org/research.

    hp2

    hp3

     

    – More –

    About Eversight: Eversight is a charitable, 501(c)(3) not-for-profit organization whose mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Our network of community eye banks—in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea—is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. For more information, visit eversightvision.org.

Honors

  • Eversight announces grant award for Northwestern University researcher, Han Peng, PhD
    08.18.2017

    hp1

    ANN ARBOR, Mich. — Eversight, a global nonprofit network of eye banks, has awarded a $15,000 Eye and Vision Research Grant to Northwestern University’s Han Peng, Ph.D.

    Dr. Peng was among nine recipients who received grants from Eversight for projects that aligned with the organization’s mission to restore sight and prevent blindness. The awards were determined by an independent review panel composed of distinguished scientists, ophthalmologists and health services researchers.

    Dr. Peng, a research assistant professor in the department of dermatology at Feinberg School of Medicine, is investigating a possible approach for improving the treatment of limbal stem cell deficiency (LSCD), a problem that is often not recognized and treated in its early stages and may lead to corneal ulceration, scarring, chronic pain and vision loss.

    LSCD occurs because of the loss of limbal epithelial stem cells, but Dr. Peng’s research hypothesizes that an enzyme his team has identified, factor inhibiting hypoxia-inducible factor 1 (FIH-1), may preserve more stem cells. The establishment of stem-cell enriched cultures has the potential to significantly improve the outcome of corneal transplantation for patients with LSCD.

    The Eye and Vision Research Grant program has awarded more than $3.5 million since 1980 to stimulate new and pioneering research. Several of these grant projects have led to larger studies and financial support from the National Institutes of Health.

    “There’s a real void when it comes to funding the initial investigative work that can launch new and groundbreaking discoveries,” said Dr. Gregory Grossman, Eversight Director of Research. “But Eversight is committed to supporting research that may potentially lead to innovative therapies and treatments.”

    The Eversight Center for Eye and Vision Research is one of the only eye bank-led programs focused on providing scientists with innovative resources they need to find new cures and treatments for blinding eye conditions. For more information, visit eversightvision.org/research.

    hp2

    hp3

     

    – More –

    About Eversight: Eversight is a charitable, 501(c)(3) not-for-profit organization whose mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Our network of community eye banks—in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea—is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. For more information, visit eversightvision.org.